Xintela AB (XINT) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.242x

Based on the latest financial reports, Xintela AB (XINT) has a cash flow conversion efficiency ratio of 0.242x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-6.74 Million ≈ $-724.90K USD) by net assets (Skr-27.88 Million ≈ $-3.00 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see XINT market cap overview for the company's overall valuation and market capitalisation.

Xintela AB - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Xintela AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Xintela AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Xintela AB ranked by their cash flow conversion efficiency. Explore XINT operating cash flow to net income to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
West International AB ST:WPAY	0.282x
NanoCMS Co. Ltd. KQ:247660	0.046x
Sebata Holdings Ltd JSE:SEB	0.031x
Ganges Securities Limited NSE:GANGESSECU	0.035x
Xenora Minerals Ltd AU:XRA	-0.038x
Mlk Foods Public Company Ltd WAR:MLK	0.004x
TOMI Environmental Solutions Inc NASDAQ:TOMZ	537.365x
UDAYSHIVAKUMAR INFRA ORD (BSE) NSE:USK	0.029x

Annual Cash Flow Conversion Efficiency for Xintela AB (2013–2024)

The table below shows the annual cash flow conversion efficiency of Xintela AB from 2013 to 2024. View XINT live share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr-5.95 Million ≈ $-640.32K	Skr-40.70 Million ≈ $-4.38 Million	6.841x	+156.41%
2023-12-31	Skr4.38 Million ≈ $471.36K	Skr-53.12 Million ≈ $-5.72 Million	-12.127x	-77.41%
2022-12-31	Skr5.78 Million ≈ $621.70K	Skr-39.49 Million ≈ $-4.25 Million	-6.836x	+37.10%
2021-12-31	Skr3.95 Million ≈ $424.76K	Skr-42.89 Million ≈ $-4.62 Million	-10.867x	-1306.49%
2020-12-31	Skr27.61 Million ≈ $2.97 Million	Skr-21.33 Million ≈ $-2.30 Million	-0.773x	+76.68%
2019-12-31	Skr9.32 Million ≈ $1.00 Million	Skr-30.89 Million ≈ $-3.32 Million	-3.313x	-377.25%
2018-12-31	Skr44.95 Million ≈ $4.84 Million	Skr-31.20 Million ≈ $-3.36 Million	-0.694x	+11.03%
2017-12-31	Skr18.41 Million ≈ $1.98 Million	Skr-14.37 Million ≈ $-1.55 Million	-0.780x	+5.90%
2016-12-31	Skr20.98 Million ≈ $2.26 Million	Skr-17.40 Million ≈ $-1.87 Million	-0.829x	+35.11%
2015-12-31	Skr7.46 Million ≈ $802.92K	Skr-9.54 Million ≈ $-1.03 Million	-1.278x	-193.91%
2014-12-31	Skr9.54 Million ≈ $1.03 Million	Skr-4.15 Million ≈ $-446.50K	-0.435x	+26.64%
2013-12-31	Skr5.08 Million ≈ $546.88K	Skr-3.01 Million ≈ $-324.14K	-0.593x	--

About Xintela AB

ST:XINT Sweden Biotechnology

Market Cap

$12.19 Million

Skr113.24 Million SEK

Market Cap Rank

#26639 Global

#563 in Sweden

Share Price

Skr0.16

Change (1 day)

+0.00%

52-Week Range

Skr0.16 - Skr0.49

All Time High

Skr8.60